Federal enforcement against CBD medical claims in the US is going strong, with the Federal Trade Commission (FTC) recently sending a warning letter to a new company about what it said were prohibited medical claims
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.